LCTX
Price
$0.68
Change
+$0.02 (+3.03%)
Updated
Jun 6 closing price
Capitalization
154.19M
59 days until earnings call
NKTR
Price
$0.67
Change
-$0.00 (-0.00%)
Updated
Jun 6 closing price
Capitalization
1.86B
59 days until earnings call
Interact to see
Advertisement

LCTX vs NKTR

Header iconLCTX vs NKTR Comparison
Open Charts LCTX vs NKTRBanner chart's image
Lineage Cell Therapeutics
Price$0.68
Change+$0.02 (+3.03%)
Volume$874.94K
Capitalization154.19M
Nektar Therapeutics
Price$0.67
Change-$0.00 (-0.00%)
Volume$2.05M
Capitalization1.86B
LCTX vs NKTR Comparison Chart
Loading...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LCTX vs. NKTR commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LCTX is a StrongBuy and NKTR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (LCTX: $0.65 vs. NKTR: $0.70)
Brand notoriety: LCTX: Not notable vs. NKTR: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LCTX: 104% vs. NKTR: 62%
Market capitalization -- LCTX: $154.19M vs. NKTR: $1.86B
LCTX [@Biotechnology] is valued at $154.19M. NKTR’s [@Biotechnology] market capitalization is $1.86B. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LCTX’s FA Score shows that 0 FA rating(s) are green whileNKTR’s FA Score has 0 green FA rating(s).

  • LCTX’s FA Score: 0 green, 5 red.
  • NKTR’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than NKTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LCTX’s TA Score shows that 5 TA indicator(s) are bullish while NKTR’s TA Score has 5 bullish TA indicator(s).

  • LCTX’s TA Score: 5 bullish, 4 bearish.
  • NKTR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, NKTR is a better buy in the short-term than LCTX.

Price Growth

LCTX (@Biotechnology) experienced а +27.63% price change this week, while NKTR (@Biotechnology) price change was +10.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

LCTX is expected to report earnings on Aug 07, 2025.

NKTR is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTR($1.86B) has a higher market cap than LCTX($154M). LCTX YTD gains are higher at: 29.811 vs. NKTR (-24.806). LCTX has higher annual earnings (EBITDA): -20.87M vs. NKTR (-86.7M). NKTR has more cash in the bank: 255M vs. LCTX (47.8M). LCTX has less debt than NKTR: LCTX (2.51M) vs NKTR (103M). NKTR has higher revenues than LCTX: NKTR (98.4M) vs LCTX (9.5M).
LCTXNKTRLCTX / NKTR
Capitalization154M1.86B8%
EBITDA-20.87M-86.7M24%
Gain YTD29.811-24.806-120%
P/E RatioN/AN/A-
Revenue9.5M98.4M10%
Total Cash47.8M255M19%
Total Debt2.51M103M2%
FUNDAMENTALS RATINGS
LCTX vs NKTR: Fundamental Ratings
LCTX
NKTR
OUTLOOK RATING
1..100
105
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
72
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
4188
P/E GROWTH RATING
1..100
6282
SEASONALITY SCORE
1..100
22n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (41) in the null industry is in the same range as NKTR (72) in the Biotechnology industry. This means that LCTX’s stock grew similarly to NKTR’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as NKTR (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to NKTR’s over the last 12 months.

LCTX's SMR Rating (96) in the null industry is in the same range as NKTR (98) in the Biotechnology industry. This means that LCTX’s stock grew similarly to NKTR’s over the last 12 months.

LCTX's Price Growth Rating (41) in the null industry is somewhat better than the same rating for NKTR (88) in the Biotechnology industry. This means that LCTX’s stock grew somewhat faster than NKTR’s over the last 12 months.

LCTX's P/E Growth Rating (62) in the null industry is in the same range as NKTR (82) in the Biotechnology industry. This means that LCTX’s stock grew similarly to NKTR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LCTXNKTR
RSI
ODDS (%)
Bearish Trend 13 days ago
86%
N/A
Stochastic
ODDS (%)
Bearish Trend 13 days ago
86%
Bullish Trend 13 days ago
74%
Momentum
ODDS (%)
Bullish Trend 13 days ago
82%
Bearish Trend 13 days ago
80%
MACD
ODDS (%)
N/A
Bullish Trend 13 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 13 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
82%
Bearish Trend 13 days ago
88%
Advances
ODDS (%)
Bullish Trend about 1 month ago
76%
Bullish Trend 13 days ago
75%
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 20 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 13 days ago
80%
Bullish Trend 13 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with ATOS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
-4.48%
ATOS - LCTX
38%
Loosely correlated
-3.13%
ATAI - LCTX
36%
Loosely correlated
+4.52%
BEAM - LCTX
35%
Loosely correlated
-0.88%
ABCL - LCTX
35%
Loosely correlated
+3.03%
NKTR - LCTX
35%
Loosely correlated
+3.68%
More

NKTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with NTLA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
+3.68%
NTLA - NKTR
50%
Loosely correlated
+3.59%
CRSP - NKTR
49%
Loosely correlated
-0.92%
RXRX - NKTR
47%
Loosely correlated
+0.11%
IPSC - NKTR
47%
Loosely correlated
-0.28%
CRNX - NKTR
46%
Loosely correlated
+1.39%
More